PRKDC and nasopharyngeal carcinoma: Linc00312 directly targets the DNA-dependent protein kinase, catalytic subunit (DNA-PKcs), blocks the interaction between DNA-PKcs and Ku80, and inactivates AKT by dephosphorylation, suppressing nonhomologous end joining (NHEJ) repair in nasopharyngeal cancer cells [53].